SL Science Holding management commentary attributes wider first-half 2026 net loss to higher operating expenses

Revenue increased 22.8% to $1.39 million, driven by larger distributor orders as the wholesale distribution model gained traction. Gross margin improved to 40.2% from 34.5%, which management attributed to more favorable procurement terms from stable supplier relationships. Research and development expenses rose 71.5% to $1.23 million, reflecting higher staff salaries and milestone payments tied to development progress; general and administrative expenses increased 16.2%, primarily because of higher office salaries following senior management expansion and increased listing-related professional fees.